Aigen Investment Management LP Acquires Shares of 17,690 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Aigen Investment Management LP acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 17,690 shares of the company's stock, valued at approximately $701,000.

Several other hedge funds have also added to or reduced their stakes in ACHC. State Street Corp raised its stake in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company's stock valued at $178,811,000 after acquiring an additional 95,613 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Acadia Healthcare by 713.3% in the fourth quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock valued at $4,396,000 after buying an additional 97,235 shares during the period. Beach Point Capital Management LP bought a new position in shares of Acadia Healthcare during the fourth quarter worth about $14,097,000. Finally, LMR Partners LLP acquired a new stake in Acadia Healthcare during the 3rd quarter valued at approximately $1,616,000.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several recent analyst reports. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Royal Bank of Canada cut their target price on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Barclays downgraded Acadia Healthcare from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $43.00 to $35.00 in a report on Friday, February 28th. KeyCorp cut their price target on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a report on Monday, March 3rd. Finally, Cantor Fitzgerald reiterated a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $56.31.

Remove Ads

Acadia Healthcare Stock Down 2.3 %

NASDAQ ACHC traded down $0.70 during trading hours on Monday, hitting $29.87. The company's stock had a trading volume of 1,844,154 shares, compared to its average volume of 1,878,968. The company has a market capitalization of $2.78 billion, a PE ratio of 9.79, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 52 week low of $28.09 and a 52 week high of $82.40. The company's 50-day simple moving average is $41.32 and its two-hundred day simple moving average is $50.05.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.